In last trading session, SpringWorks Therapeutics Inc (NASDAQ:SWTX) saw 5.14 million shares changing hands with its beta currently measuring 0.86. Company’s recent per share price level of $59.93 trading at $4.2 or 7.54% at ring of the bell on the day assigns it a market valuation of $4.46B. That closing price of SWTX’s stock is at a discount of -0.12% from its 52-week high price of $60.00 and is indicating a premium of 52.93% from its 52-week low price of $28.21.

For SpringWorks Therapeutics Inc (SWTX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.12. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.72 in the current quarter.

SpringWorks Therapeutics Inc (NASDAQ:SWTX) trade information

Upright in the green during last session for gaining 7.54%, in the last five days SWTX remained trading in the green while hitting it’s week-highest on Thursday, 02/20/25 when the stock touched $59.93 price level, adding 3.34% to its value on the day. SpringWorks Therapeutics Inc’s shares saw a change of 65.87% in year-to-date performance and have moved 1.10% in past 5-day. SpringWorks Therapeutics Inc (NASDAQ:SWTX) showed a performance of 64.87% in past 30-days.

Wall Street analysts have assigned a consensus price target of 78 to the stock, which implies a rise of 23.17% to its current value. Analysts have been projecting 78 as a low price target for the stock while placing it at a high target of 78. It follows that stock’s current price would drop -30.15% in reaching the projected high whereas dropping to the targeted low would mean a loss of -30.15% for stock’s current value.

SpringWorks Therapeutics Inc (SWTX) estimates and forecasts

This year revenue growth is estimated to rise 80.92% from the last financial year’s standing.

2 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 66.7M for the same. And 2 analysts are in estimates of company making revenue of 75.96M in the next quarter. Company posted 21.01M and 59.73M of sales in current and next quarters respectively a year earlier.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -24.25% during past 5 years.

SpringWorks Therapeutics Inc (NASDAQ:SWTX)’s Major holders

FMR LLC is the top institutional holder at SWTX for having 11.11 million shares of worth $418.6 million. And as of 2024-06-30, it was holding 15.0638 of the company’s outstanding shares.

The second largest institutional holder is VANGUARD GROUP INC, which was holding about 6.54 million shares on 2024-06-30. The number of shares represents firm’s hold over 8.8715 of outstanding shares, having a total worth of $246.53 million.

On the other hand, Fidelity Growth Company Fund and Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 3.56 shares of worth $213.49 million or 4.79% of the total outstanding shares. The later fund manager was in possession of 2.1 shares on Sep 30, 2024 , making its stake of worth around $125.73 million in the company or a holder of 2.82% of company’s stock.